The money will predominantly be used to refinance the debt the company had taken to fund its acquisition of diagnostics chain Thyrocare last year.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/dITmAgW
via IFTTT
The money will predominantly be used to refinance the debt the company had taken to fund its acquisition of diagnostics chain Thyrocare last year.
No comments:
Post a Comment